Articles Tagged With: vaginosis
-
A New Treatment for Recurrent Bacterial Vaginosis?
Recurrent bacterial vaginosis is a problem that affects many women, with an estimated 50% of women developing a recurrence within 12 months of treatment. The authors of this study tested the efficacy of a novel product, Lactobacillus crispatus CTV-05 (Lactin-V), in reducing bacterial vaginosis recurrence in this phase 2b clinical trial.
-
A New Treatment for Recurrent Bacterial Vaginosis?
In this randomized controlled trial of 228 women, Lactobacillus crispatus CTV-05 (Lactin-V) applied vaginally for 11 weeks reduced the incidence of recurrent bacterial vaginosis from 45% in the placebo arm to 30% in the Lactin-V arm.
-
A New Treatment for Recurrent Bacterial Vaginosis?
In this randomized, controlled trial of 228 women, Lactobacillus crispatus CTV-05 (Lactin-V) applied vaginally for 11 weeks reduced the incidence of recurrent bacterial vaginosis from 45% in the placebo arm to 30% in the Lactin-V arm.
-
Does Treatment of Bacterial Vaginosis Prevent Spontaneous Preterm Birth?
In this randomized, controlled trial from France, screening for and treatment of bacterial vaginosis in pregnant women at low risk for preterm birth with oral clindamycin or placebo did not reduce the rate of spontaneous preterm birth between 16 and 36 weeks.
-
Secnidazole Oral Granules (Solosec)
The FDA has approved the first oral single-dose treatment for bacterial vaginosis in adult women.